Board change detailed in ECARX (ECX) Form 6-K and F-3 reference

Rhea-AI Filing Summary

ECARX Holdings Inc. filed a Form 6-K as a foreign private issuer to furnish a press release titled “ECARX Announces Board Change.”

The report states that this Form 6-K, including its exhibit, is incorporated by reference into post-effective amendment No. 2 to the company’s registration statement on Form F-1 on Form F-3 (File No. 333-271861), making it part of that registration statement from the date it is furnished unless later superseded. ECARX reports under Form 20-F and lists its principal executive office in London.

Form 6-K: How Foreign Companies Report to the SEC →

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of October 2025

Commission File Number: 001-41576

ECARX Holdings Inc.

(Translation of registrant’s name into English)

Second Floor North

International House

1 St. Katharine’s Way

London E1W 1UN

United Kingdom

+44 73 8531 8413

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F x      Form 40-F o

164828.02-BEISR01A - MSW

Explanatory Note

This current report on Form 6-K, including the exhibit hereto, is incorporated by reference into the post-effective amendment No. 2 to the registration statement on Form F-1 on Form F-3 (File No. 333-271861) and shall be a part of such registration statement from the date on which this current report is furnished, to the extent not superseded by documents or reports subsequently filed or furnished.

164828.02-BEISR01A - MSW

EXHIBIT INDEX

Exhibit No.			Description
99.1			Press Release — ECARX Announces Board Change

164828.02-BEISR01A - MSW

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

ECARX Holdings Inc.

By						/s/ Jing (Phil) Zhou
Name			:			Jing (Phil) Zhou
Title			:			Chief Financial Officer

Date: October 31, 2025

164828.02-BEISR01A - MSW

FAQ

What does ECARX Holdings Inc. disclose in this Form 6-K (ECX)?

ECARX Holdings Inc. furnishes a Form 6-K to provide a press release titled “ECARX Announces Board Change”, indicating a change in its board of directors.

How is this ECARX (ECX) Form 6-K used in the company’s registration statement?

The Form 6-K, including its exhibit, is incorporated by reference into post-effective amendment No. 2 to ECARX’s registration statement on Form F-1 on Form F-3 (File No. 333-271861).

Which annual report form does ECARX Holdings Inc. (ECX) use?

ECARX Holdings Inc. indicates that it files annual reports under Form 20-F, confirming its status as a foreign private issuer.

What exhibit is attached to this ECARX (ECX) Form 6-K?

The exhibit index lists Exhibit 99.1 as a press release titled “ECARX Announces Board Change”.

Who signed this ECARX (ECX) Form 6-K and in what capacity?

The Form 6-K is signed by Jing (Phil) Zhou, who is identified as the company’s Chief Financial Officer.

Where is ECARX Holdings Inc.’s principal executive office located?

The principal executive office of ECARX Holdings Inc. is listed as Second Floor North, International House, 1 St. Katharine’s Way, London E1W 1UN, United Kingdom.